Aug 4 (Reuters)-
SymBio Pharmaceuticals Limited
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2021 Jun 30, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.15 1.36 9.15
(+131.3 pct) (-32.1 pct) (+206.4 pct)
Operating loss 194 mln loss 1.84 1.36
Recurring loss 203 mln loss 1.88 1.35
Net loss 205 mln loss 1.88 1.15
EPS loss 5.37 yen loss 62.47 yen 29.99 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - SymBio Pharmaceuticals Limited.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T